Skip to main content
OpenTrials

Clinical trial condition

Cytopenia

Explore clinical trials studying Cytopenia. Study availability and eligibility vary by location and protocol.

1,007 public trials 191 recruiting studies
Refine in advanced search Browse all conditions

Cytopenia trial results

Completed

Ravulizumab in Thrombotic Microangiopathy After Hematopoietic Stem Cell Transplant

NCT04543591

Conditions
Blood Platelet Disorders, Cytopenia, Hematologic Diseases, +4 more
Locations
  • Research Site Tampa, Florida, United States
  • Research Site Grosse Pointe Farms, Michigan, United States
  • Research Site Durham, North Carolina, United States
  • Research Site Pittsburgh, Pennsylvania, United States
View all 66 locations
View Trial Details
Completed

A Study of TAK-755 (rADAMTS13) With Little to No Plasma Exchange (PEX) Treatment in Adults With Immune-mediated Thrombotic Thrombocytopenic Purpura (iTTP)

NCT05714969

Conditions
Blood Coagulation Disorders, Blood Platelet Disorders, Cytopenia, +14 more
Locations
  • University of Florida - Shands Gainesville, Florida, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Brigham and Women's Hospital Boston, Massachusetts, United States
  • Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
View all 22 locations
View Trial Details
Completed

Evaluation of Avatrombopag for the Treatment of Thrombocytopenia in Japanese Adults With Chronic ITP

NCT05369208

Conditions
Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
Locations
  • Sobi Site 105 Toyohashi, Aichi-ken, Japan
  • Sobi Site 110 Tōon, Ehime, Japan
  • Sobi Site 118 Iizuka-shi, Fukuoka, Japan
  • Sobi Site 116 Kitakyushu, Fukuoka, Japan
View all 19 locations
View Trial Details
Completed

Avatrombopag for the Treatment of Thrombocytopenia in Pediatric Subjects With Immune Thrombocytopenia for ≥6 Months

NCT04516967

Conditions
Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
Locations
  • Site 112 Phoenix, Arizona, United States
  • Site 103 Long Beach, California, United States
  • Site 119 Orange, California, United States
  • Site 109 Sacramento, California, United States
View all 62 locations
View Trial Details
Completed

Efficacy and Safety of Iptacopan (LNP023) in Adult Patients With Atypical Hemolytic Uremic Syndrome Naive to Complement Inhibitor Therapy

NCT04889430

Conditions
Anemia, Anemia, Hemolytic, Atypical Hemolytic Uremic Syndrome, +14 more
Locations
  • USC Norris Cancer Center Los Angeles, California, United States
  • Univ of California at Los Angeles Los Angeles, California, United States
  • Univ Cali Irvine ALS Neuromuscular Orange, California, United States
  • Univ of California at Sacramento Sacramento, California, United States
View all 36 locations
View Trial Details

Related conditions